Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Accepts healthy volunteers Results available

Safety and Effectiveness of Sculptra Aesthetic for Correction of Cheek Wrinkles

ClinicalTrials.gov ID: NCT04124692

Public ClinicalTrials.gov record NCT04124692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of Sculptra Aesthetic for Correction of Cheek Wrinkles.

Study identification

NCT ID
NCT04124692
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Galderma R&D
Industry
Enrollment
149 participants

Conditions and interventions

Conditions

Interventions

  • Sculptra Aesthetic new dilution Device

Device

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2019
Primary completion
Aug 11, 2021
Completion
Aug 11, 2021
Last update posted
Nov 17, 2023

2019 – 2021

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
12
Facility City State ZIP Site status
Galderma Research Site Scottsdale Arizona 85255
Galderma Research Site Encino California 91436
Galderma Research Site Redondo Beach California 90277
Galderma Research Site San Diego California 92121
Galderma Research Site Washington D.C. District of Columbia 20037
Galderma Research Site Coral Gables Florida 33143
Galderma Research Site Alpharetta Georgia 30022
Galderma Research Site New Orleans Louisiana 70115
Galderma Research Site Rockville Maryland 20852
Galderma Research Site New York New York 10021
Galderma Research Site New York New York 10028
Galderma Research Site Dallas Texas 75254
Galderma Research Site Spring Texas 77388

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04124692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04124692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →